Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03980808 · ClinicalTrials.gov registry record · NA
American Sign Language-Accessible Diabetes Education
A NA study, sponsored by Georgia Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT03980808 is a NA study that has completed, run by Georgia Institute of Technology. The registered enrollment target is 41 participants.
The verdict
NCT03980808, a NA study, has completed, sponsored by Georgia Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
ASL-ADE will evaluate the efficacy of an ASL-interpreted diabetes educational intervention to the end of improving the health literacy of the target population and addressing their disparate health outcomes.
Interventions
- BEHAVIORAL Control Intervention
- BEHAVIORAL American Sign Language-Accessible Diabetes Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2020-10-29 |
| Est. Completion | 2021-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03980808
The ClinicalTrials.gov registry entry for NCT03980808 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgia Institute of Technology, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Intervention is the first listed.
NCT03980808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03980808 about?
NCT03980808 is a clinical study titled "American Sign Language-Accessible Diabetes Education". ASL-ADE will evaluate the efficacy of an ASL-interpreted diabetes educational intervention to the end of improving the health literacy of the target population and addressing their disparate health outcomes.
What is the current status of trial NCT03980808?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2020-10-29. Estimated completion is 2021-01-26.
What interventions are being tested in trial NCT03980808?
The interventions under investigation include: Control Intervention (BEHAVIORAL), American Sign Language-Accessible Diabetes Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT03980808?
This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.